PHARMING GROUP NV - ADR (PHAR:NASDAQ)
$9.79 0.26 (2.7282%)
Analysed PHARMING GROUP NV - ADR (PHAR:NASDAQ) News Sources
Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
04-08-2026
yahoo.com
Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older
13-08-2026
yahoo.com
Form 8.3
14-08-2026
yahoo.com
Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS
25-09-2026
yahoo.com
Pharming announces CEO transition
29-09-2026
yahoo.com
Pharming Group (PHGUF) (Q2 2026) Earnings Call Highlights: Joenja Surges 40% as Ruconest Faces ...
30-07-2026
yahoo.com
Pharming Group to participate in September investor conferences
09-09-2026
yahoo.com
FDA approves Pharming's Joenja® as first treatment for children with APDS in the U.S.
11-09-2026
yahoo.com
Pharming Group (PHAR) Expands Joenja’s Pediatric Label. Can Growth Offset RUCONEST Weakness?
16-09-2026
yahoo.com
Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026
22-09-2026
yahoo.com
What is the current price of PHARMING GROUP NV - ADR (PHAR:NASDAQ)?
The current price of PHARMING GROUP NV - ADR (PHAR:NASDAQ) is $9.79.
PHARMING GROUP NV - ADR (PHAR:NASDAQ) absolute price change since previous trading day?
The absolute price change of PHARMING GROUP NV - ADR (PHAR:NASDAQ) since the previous trading day is $0.26.
PHARMING GROUP NV - ADR (PHAR:NASDAQ) percentage price change since previous trading day?
The percentage price change of PHARMING GROUP NV - ADR (PHAR:NASDAQ) since the previous trading day is 2.7282%.
What is the most recent average sentiment score for PHARMING GROUP NV - ADR (PHAR:NASDAQ)?
The most recent average sentiment score for PHARMING GROUP NV - ADR (PHAR:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for PHARMING GROUP NV - ADR (PHAR:NASDAQ)?
The most recent sentiment for PHARMING GROUP NV - ADR (PHAR:NASDAQ) is .
SEC-8K** Filing Available For PHARMING GROUP NV - ADR (PHAR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.